The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
SID87544824 ID: ALA1736901
PubChem CID: 27869236
Max Phase: Preclinical
Molecular Formula: C18H22N4O3S
Molecular Weight: 374.47
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: NS(=O)(=O)c1ccc(NC(=O)N2CCN(Cc3ccccc3)CC2)cc1
Standard InChI: InChI=1S/C18H22N4O3S/c19-26(24,25)17-8-6-16(7-9-17)20-18(23)22-12-10-21(11-13-22)14-15-4-2-1-3-5-15/h1-9H,10-14H2,(H,20,23)(H2,19,24,25)
Standard InChI Key: VJPQXXSBUBPQDB-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
-0.0855 3.8471 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-0.0855 4.6721 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.9105 3.8471 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.3435 0.5471 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.6290 -0.6904 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.0855 0.5471 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.6290 -2.3404 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.7395 3.8471 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.0855 3.0221 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0855 1.3721 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6290 0.1346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6290 2.6096 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7999 2.6096 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6290 1.7846 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7999 1.7846 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3435 -1.1029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0855 -1.1029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3435 -1.9279 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0855 -1.9279 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6290 -3.1654 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0855 -3.5779 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0855 -4.4029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7999 -3.1654 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7999 -4.8154 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5144 -3.5779 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5144 -4.4029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
1 3 2 0
1 8 1 0
1 9 1 0
4 11 2 0
5 11 1 0
5 16 1 0
5 17 1 0
6 10 1 0
6 11 1 0
7 18 1 0
7 19 1 0
7 20 1 0
9 12 2 0
9 13 1 0
10 14 2 0
10 15 1 0
12 14 1 0
13 15 2 0
16 18 1 0
17 19 1 0
20 21 1 0
21 22 2 0
21 23 1 0
22 24 1 0
23 25 2 0
24 26 2 0
25 26 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 374.47Molecular Weight (Monoisotopic): 374.1413AlogP: 1.68#Rotatable Bonds: 4Polar Surface Area: 95.74Molecular Species: NEUTRALHBA: 4HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.25CX Basic pKa: 6.95CX LogP: 1.50CX LogD: 1.37Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.85Np Likeness Score: -1.96
References 1. PubChem BioAssay data set, 2. Congiu C, Onnis V, Deplano A, Balboni G, Dedeoglu N, Supuran CT.. (2015) Synthesis of sulfonamides incorporating piperazinyl-ureido moieties and their carbonic anhydrase I, II, IX and XII inhibitory activity., 25 (18): [PMID:26233435 ] [10.1016/j.bmcl.2015.07.060 ]